Aurobindo Pharma Ltd has announced that Company has received 5 product approvals from the US Food & Drug Administration since October 2007 for the US market. These approvals include two Paragraph IV products - Finasterice Tablets USP and Glyburide & Metformin Hydrochloride Tablets.
The products approved are as follows:
1. Glyburide Tablets USP - 1.25, 2.5 & 5mg
2. Torsemide Tablets - 5, 10, 20 and 100mg
3. Finasteride Tablets USP - 5 mg
4. Atenolol Tablets USP - 25, 50 and 100mg
5. Glyburide & Mefformin Hydrochloride Tablets - 1.25 / 250, 2.5 / 500 & 5 / 500mg
Company now has a total of 59 ANDAs approved by the USFDA.
The stock was trading at Rs.509, down by Rs.9.45 or 1.82%. The stock hit an intraday high of Rs.524.40 and low of Rs.490.
The total traded quantity was 67055 compared to 2 week average of 16240.
|
